Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Principles of immunosuppression.

G L Chan1, S A Gruber, K L Skjei

  • 1Department of Pharmacy Practice, University of Minnesota Hospital and Clinic, Minneapolis.

Critical Care Clinics
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Impact of maternal risky behaviors on the behaviors of children born to adolescent and young mothers].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2018
Same author

The effect of healthy dietary consumption on executive cognitive functioning in children and adolescents: a systematic review.

The British journal of nutrition·2016
Same author

The impact of initiation: Early onset marijuana smokers demonstrate altered Stroop performance and brain activation.

Developmental cognitive neuroscience·2015
Same author

Split sex ratios in ants with multiple mating.

Trends in ecology & evolution·2011
Same author

Spontaneous hernia through the posterior rectus abdominis sheath: case report and review of the published literature 1937-2008.

Hernia : the journal of hernias and abdominal wall surgery·2009
Same author

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.

Neurology·2009
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Cyclosporine (CSA) regimens achieve excellent 1-year transplant survival. However, long-term graft survival remains a challenge, necessitating focus on newer immunosuppressants like monoclonal antibodies (mAbs) for improved outcomes.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Immunosuppression

Background:

  • Current cyclosporine (CSA)-based immunosuppressive regimens achieve high 1-year graft survival rates (80%-90%) in primary cadaveric transplants.
  • Long-term follow-up reveals a concerning trend of allograft attrition beyond the first year in CSA-treated patients.
  • Optimizing current immunosuppressive strategies and exploring novel agents are crucial for enhancing long-term transplant success.

Purpose of the Study:

  • To evaluate the long-term impact and efficacy of cyclosporine (CSA) in organ transplantation.
  • To identify strategies for improving long-term allograft survival rates at 5 to 10 years post-transplant.
  • To assess the role of newer immunosuppressive agents, including monoclonal antibodies (mAbs), in overcoming current limitations.

Main Methods:

Related Experiment Videos

  • Review and analysis of long-term follow-up data from patients receiving CSA-containing immunosuppressive regimens.
  • Evaluation of the effectiveness of potent combination immunosuppression protocols.
  • Consideration of emerging immunosuppressive therapies, such as monoclonal antibodies (mAbs).

Main Results:

  • High 1-year graft survival is routinely achievable with CSA-based regimens.
  • A significant trend of late allograft loss is observed in patients treated long-term with CSA.
  • Potential complications of CSA include nephrotoxicity and an increased risk of neoplasms, requiring careful monitoring and dosing.

Conclusions:

  • Future research should prioritize improving long-term (5-10 year) allograft survival.
  • Careful management of CSA is necessary to avoid underdosing and late rejection, while monitoring for long-term side effects.
  • Monoclonal antibodies (mAbs) represent a promising advancement for specific immunosuppression, potentially reducing complications associated with current regimens.